🇺🇸 FDA
Pipeline program

CUE-102

CUE-102-01

Phase 1 small_molecule completed

Quick answer

CUE-102 for Colorectal Cancer is a Phase 1 program (small_molecule) at Cue Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Cue Biopharma
Indication
Colorectal Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials